Performance on complex memory tests is associated with ß-amyloid in individuals at risk of developing Alzheimer's disease

被引:2
|
作者
Kjeldsen, Pernille Louise [1 ,2 ,3 ,10 ]
Damholdt, Malene Flensborg [1 ,4 ]
Madsen, Lasse Stensvig [1 ,5 ]
Nissen, Peter Henrik [1 ,6 ]
Aanerud, Joel Fredrik Astrup [2 ]
Parbo, Peter [1 ,7 ]
Ismail, Rola [8 ]
Kaasing, Malene [1 ,5 ]
Eskildsen, Simon Fristed [1 ,5 ]
Ostergaard, Leif [1 ,5 ]
Brooks, David James [1 ,2 ,5 ,9 ]
机构
[1] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Nucl Med & PET, Aarhus, Denmark
[3] Aalborg Univ Hosp, Dept Neurol, Aalborg, Denmark
[4] Aarhus Univ, Dept Psychol, Aarhus, Denmark
[5] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark
[6] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark
[7] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[8] Sygehus Lillebaelt, Dept Nucl Med, Vejle, Denmark
[9] Univ Newcastle Tyne, Translat & Clin Res Inst, Newcastle Upon Tyne, Northumberland, England
[10] Aarhus Univ Hosp, Palle Juul Jensens Blvd 165, DK-8200 Aarhus, Denmark
基金
欧盟地平线“2020”;
关键词
amyloid imaging; APOE4; memory; neuropsychological testing; preclinical Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; VERBAL-LEARNING TEST; BRAIN; BETA; VALIDATION; BIOMARKERS; DEPOSITION; FEATURES; DECLINE;
D O I
10.1111/jnp.12332
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The pathophysiological development of Alzheimer's disease (AD) begins in the brain years before the onset of clinical symptoms. The accumulation of beta-amyloid (A ss) is thought to be the first cortical pathology to occur. Carrying one apolipoprotein E ( APOE) epsilon 4 allele increases the risk of developing AD at least 2-3 times and is associated with earlier A ss accumulation. Although it is difficult to identify A ss-related cognitive impairment in early AD with standard cognitive tests, more sensitive memory tests may be able to do this. We sought to examine associations between A ss and performance on three tests within three subdomains of memory, verbal, visual, and associative memory, to elucidate which of these tests were sensitive to A ss-related cognitive impairment in at-risk subjects. 55 APOE e4 carriers underwent MRI, C-11-Pittsburgh Compound B (PiB) PET, and cognitive testing. A composite cortical PiB SUVR cut-off score of 1.5 was used to categorise subjects as either APOE epsilon 4 A ss+ or APOE epsilon 4 A ss-. Correlations were carried out using cortical surface analysis. In the whole APOE epsilon 4 group, we found significant correlations between A ss load and performance on verbal, visual, and associative memory tests in widespread cortical areas, the strongest association being with performance on associative memory tests. In the APOE epsilon 4 A ss+ group, we found significant correlations between A ss load and performance of verbal and associative, but not visual, memory in localised cortical areas. Performance on verbal and associative memory tests provides sensitive markers of early A ss-related cognitive impairment in at-risk subjects.
引用
收藏
页码:120 / 135
页数:16
相关论文
共 50 条
  • [41] Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease
    M. M. Verbeek
    Irene Otte-Höller
    Robert Veerhuis
    Dirk J. Ruiter
    Robert M. W. De Waal
    Acta Neuropathologica, 1998, 96 : 628 - 636
  • [42] Androgen regulation of β-amyloid protein and the risk of Alzheimer's disease
    Rosario, Emily R.
    Pike, Christian J.
    BRAIN RESEARCH REVIEWS, 2008, 57 (02) : 444 - 453
  • [43] Presenilin-1 is associated with Alzheimer's disease amyloid
    Wisniewski, T
    Dowjat, WK
    Permanne, B
    Palha, J
    Kumar, A
    Gallo, G
    Frangione, B
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (02): : 601 - 610
  • [44] Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
    Coppus, Antonia M. W.
    Schuur, Maaike
    Vergeer, Jeanet
    Janssens, A. Cecile J. W.
    Oostra, Ben A.
    Verbeek, Marcel M.
    van Duijn, Cornelia M.
    NEUROBIOLOGY OF AGING, 2012, 33 (09) : 1988 - 1994
  • [45] Antihypertensive drugs and the risk of developing Alzheimer's disease
    Imfeld, P.
    Brauchli, Y. B.
    Jick, S. S.
    Meier, C. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 409 - 409
  • [46] ERT reduces the risk of developing Alzheimer's disease
    Waring, S
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (04) : 1166 - 1166
  • [47] Head injury and the risk of developing Alzheimer's Disease
    Corrada, MM
    Costa, PT
    Kawas, CH
    NEUROLOGY, 1997, 48 (03) : 5054 - 5054
  • [48] Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals
    Wirth, Miranka
    Madison, Cindee M.
    Rabinovici, Gil D.
    Oh, Hwamee
    Landau, Susan M.
    Jagust, William J.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (13): : 5553 - 5563
  • [49] Alcohol use and the risk of developing Alzheimer's disease
    Tyas, SL
    ALCOHOL RESEARCH & HEALTH, 2001, 25 (04) : 299 - 306
  • [50] Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease
    Chatterjee, Pratishtha
    Elmi, Mitra
    Goozee, Kathryn
    Shah, Tejal
    Sohrabi, Hamid R.
    Dias, Cintia B.
    Pedrini, Steve
    Shen, Kaikai
    Asih, Prita R.
    Dave, Preeti
    Taddei, Kevin
    Vanderstichele, Hugo
    Zetterberg, Henrik
    Blennow, Kaj
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 775 - 783